BCBS of Michigan’s Opioid Prescribing Limits Show Promising Results

pills
October 26

After Blue Cross Blue Shield of Michigan implemented a five-day opioid prescribing limit in 2018, members who underwent general surgeries were prescribed and filled fewer prescriptions and had similar patient-reported outcomes compared with enrollees who had procedures before the program was initiated, according to a study published in JAMA Health Forum on Oct. 13.

James Grant, M.D., BCBS of Michigan’s chief medical officer, tells AIS Health, a division of MMIT, that the results show payers can steer people away from potentially addictive opioids without having a negative impact on their pain management.

0
0 Comments
© 2023 MMIT
Tim Casey

Tim Casey

Tim has worked as a reporter and editor for more than 20 years. Before joining AIS Health in December 2021, he was a business reporter covering the commercial real estate industry’s capital markets for four years. He previously covered health care business issues for two medical publishing companies and high school, college and professional sports for the Sacramento Bee newspaper. Tim has a B.A. in Psychology from the University of Notre Dame and an M.B.A. from Georgetown University.

Related Posts

pills-in-hands
June 8

Buprenorphine Coverage Is Improving, but Access Barriers Remain

READ MORE
pills
June 15

Buprenorphine Remains Underutilized Despite Relaxed Regulations

Read More
pills-in-hand
April 13

Rx Oversight Issues at Federal Workers’ Comp Program Endangered Patients, Audit Says

READ MORE

The Latest

Premium Categories

enhance-patient-assistance-programs

Meet Our Reporters

Tags

Benefit ManagementData & AnalyticsPayer/Provider Relations

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today